Comparison of ionic polymers in the targeted drug delivery applications as the coating materials on the Fe3O4 nanoparticles

Synthesis and Characterization of Fe3O4/Chitosan/TiO2 Nanoparticle Novel Nanocarrier and Investigation of In Vitro Release of Vancomycin on HeLa Cancer Cell

Nanocarrier systems have gained significant attention in recent decades as an alternative to conventional drug delivery methods, which often suffer from various limitations. In this study, Fe3O4/chitosan/TiO2 nanoparticles were synthesized as a novel nanocarrier for targeted drug delivery. The loading efficiency and controlled release behavior of vancomycin from the nanocarrier were evaluated under in vitro conditions using HeLa cancer cells. The in vitro study of the drug release behavior showed that the implementation of a titania coating significantly diminishes the drug release rate. Specifically, approximately 90 ± 0.2% of the drug is released over a period of 16 h for samples without the titania coating, while samples with the coating exhibit a release time of 25 h. The MTT assay indicates that the application of TiO2 nanoparticles on the nanocarrier resulted in a decrease in cell viability from 90 ± 3% to 50 ± 2% at concentrations of 100 μg/mL and 500 μg/mL, respectively. These findings highlight the potential of the Fe3O4/chitosan/TiO2 nanocarrier as an efficient system for controlled and targeted drug delivery applications.

Hyperthermia and doxorubicin release by Fol-LSMO nanoparticles induce apoptosis and autophagy in breast cancer cells

Background: Studies on the anticancer effects of lanthanum strontium manganese oxide (LSMO) nanoparticles (NPs)-mediated hyperthermia at cellular and molecular levels are scarce. Materials & methods: LSMO NPs conjugated with folic acid (Fol-LSMO NPs) were synthesized, followed by doxorubicin-loading (DoxFol-LSMO NPs), and their effects on breast cancer cells were investigated. Results: Hyperthermia (45°C) and combination treatments exhibited the highest (∼95%) anticancer activity with increased oxidative stress. The involvement of intrinsic mitochondria-mediated apoptotic pathway and induction of autophagy was noted. Cellular and molecular evidence confirmed the crosstalk between apoptosis and autophagy, involving Beclin1, Bcl2 and Caspase-3 genes with free reactive oxygen species presence. Conclusion: The study confirmed hyperthermia and doxorubicin release by Fol-LSMO NPs induces apoptosis and autophagy in breast cancer cells.

Ultra pH-sensitive nanocarrier based on Fe2O3/chitosan/montmorillonite for quercetin delivery

Harmful side effects of the chemotherapeutic agent have been investigated in many recent studies. Since Fe₂O₃ nanoparticles have proper porosity, they are capable for loading noticeable amount of drugs and controlled release. We developed Fe₂O₃/chitosan/montmorillonite nanocomposite. Quercetin (QC) nanoparticles, which have fewer side effects than chemical anti-tumor drugs, were encapsulated in the synthesized nanocarrier and were characterized by X-ray diffraction (XRD), Fourier transforms infrared spectroscopy (FTIR), field emission scanning electron microscopy (FE-SEM), vibrating sample magnetometer (VSM), dynamic light scattering (DLS), and zeta potential. For quercetin, the encapsulation efficiency and the loading efficiency of the drug in Fe₂O₃-CS-MMT@QC were found to be about 94% and 57%, respectively. The release profile of QC in different mediums indicated pH-dependency and controlled release of the nanocomposite, adhering to The Weibull kinetic model. Biocompatibility of the Fe₂O₃/CS/MMT nanoparticles against the MCF-7 cells was shown by MTT assay and confirmed by flow cytometry. These data demonstrate that the designed Fe₂O₃-CS-MMT@QC would have potential drug delivery to treat cancer cells.

Pharmaceutical Aspects of Nanocarriers for Smart Anticancer Therapy

Drug delivery to tumor sites using nanotechnology has been demonstrated to overcome the drawbacks of conventional anticancer drugs. Altering the surface shape and geometry of nanocomposites alters their chemical properties, which can confer multiple attributes to nanocarriers for the treatment of cancer and their use as imaging agents for cancer diagnosis. However, heterogeneity and blood flow in human cancer limit the distribution of nanoparticles at the site of tumor tisues. For targeted delivery and controlled release of drug molecules in harsh tumor microenvironments, smart nanocarriers combined with various stimuli-responsive materials have been developed. In this review, we describe nanomaterials for smart anticancer therapy as well as their pharmaceutical aspects including pharmaceutical process, formulation, controlled drug release, drug targetability, and pharmacokinetic or pharmacodynamic profiles of smart nanocarriers. Inorganic or organic-inorganic hybrid nanoplatforms and the electrospinning process have also been briefly described here.

Titania Nanofluids Based on Natural Ester: Cooling and Insulation Properties Assessment

The assessment of a TiO2 vegetal-based dielectric nanofluid has been carried out, and its characteristics and behavior have been tested and compared with a previously tested maghemite nanofluid. The results obtained reflect a similar affectation of the main properties, with a maximal improvement of the breakdown voltage of 33% at 0.5 kg/m3, keeping the thermal conductivity and the viscosity almost constant, especially the first one. This thermal characterization agrees with the results obtained when applying the TiO2 optimal nanofluid in the cooling of an experimental setup, with a slightly worse performance than the base fluid. Nevertheless, this performance is the opposite to that noticed with the ferrofluid, which was capable of improving the cooling of the transformer and decreasing its temperature. The similarities between the characterizations of both nanofluids, the differences in their cooling performances and their different magnetic natures seem to point out the presence of additional thermomagnetic buoyancy forces to support the improvement of the cooling.

Implication of Magnetic Nanoparticles in Cancer Detection, Screening and Treatment

During the last few decades, magnetic nanoparticles have been evaluated as promising materials in the field of cancer detection, screening, and treatment. Early diagnosis and screening of cancer may be achieved using magnetic nanoparticles either within the magnetic resonance imaging technique and/or sensing systems. These sensors are designed to selectively detect specific biomarkers, compounds that can be related to the onset or evolution of cancer, during and after the treatment of this widespread disease. Some of the particular properties of magnetic nanoparticles are extensively exploited in cancer therapy as drug delivery agents to selectively target the envisaged location by tailored in vivo manipulation using an external magnetic field. Furthermore, individualized treatment with antineoplastic drugs may be combined with magnetic resonance imaging to achieve an efficient therapy. This review summarizes the studies about the implications of magnetic nanoparticles in cancer diagnosis, treatment and drug delivery as well as prospects for future development and challenges of magnetic nanoparticles in the field of oncology.